INTRODUCTION {#s1}
============

Whereas the fetal consequences of heavy alcohol intake during pregnancy have been clear for some time ([@DDP388C1]), the effect of moderate drinking remains controversial ([@DDP388C2]). The advice to pregnant women is generally to abstain, since no amount of alcohol is known to be safe ([@DDP388C3]). However, this is based on a precautionary principle rather than on solid evidence. Even where associations have been confirmed, these have generally been weak ([@DDP388C4]) and could still be due to residual confounding ([@DDP388C5],[@DDP388C6]) and under-reporting of prenatal alcohol use ([@DDP388C7],[@DDP388C8]). Both of these potentially interfere with establishing causality of the associations of maternal alcohol intake with various outcomes \[from fetal growth and neurodevelopment ([@DDP388C9]) to childhood mental health problems such as hyperactivity or inattention ([@DDP388C10]) or conduct disorder ([@DDP388C11])\] and deriving evidence-based messages for the public.

Genetic variants associated with alcohol intake or metabolism have been proposed as unbiased and unconfounded markers of the effect of ingested ethanol or its metabolites (acetate, acetaldehyde)---an approach known as Mendelian randomization ([@DDP388C12],[@DDP388C13]). A single nucleotide polymorphism (SNP) exists in the acetaldehyde dehydrogenase gene *ALDH2*, which encodes an enzyme unable to clear acetaldehyde and often causes individuals carrying the variant to abstain from alcohol or drink in moderation ([@DDP388C14]). The use of *ALDH2* as an instrument has proved valuable in Mendelian randomization studies ([@DDP388C15],[@DDP388C16]). However, the potential relevance of this variant is limited to East-Asian populations as it is absent in populations of European origin ([@DDP388C17]).

Identifying suitable instrument for Mendelian randomization studies of the consequences of prenatal alcohol exposure in European populations remains a challenge. The most natural choice of candidates is alcohol dehydrogenase (*ADH*) genes, which catalyze the first step of alcohol metabolism oxidizing ethanol into acetaldehyde. A role for these variants in alcohol intake, metabolism and dependence has been suggested by both genome-wide linkage ([@DDP388C18]--[@DDP388C21]) and candidate gene ([@DDP388C22]--[@DDP388C25]) studies, and in particular a non-synonymous variant in *ADH1B* has been implicated. The rare variant is thought to encode an enzyme which accelerates ethanol clearance ([@DDP388C26]) (based on studies *in vitro*), but there is limited evidence for association with alcohol metabolism *in vivo* ([@DDP388C22],[@DDP388C27],[@DDP388C28],[@DDP388C29]). The extent to which this SNP is associated with alcohol intake among pregnant women is unclear. On the one hand, the pressures to cut down or quit drinking alcohol ([@DDP388C30]--[@DDP388C32]) might increase the relative contribution of genetic variation to alcohol intake and, on the other; pregnancy might result in metabolic changes and modify the effect of the *ADH1B* and other *ADH* variants. A systematic review on the incidence of fetal alcohol syndrome in populations of European and African origins found that this SNP was associated with offspring outcome ([@DDP388C33]), but highlighted the need to better understand the extent to which the *ADH1B* variant is associated with prenatal alcohol use ([@DDP388C33]).

This study seeks to validate genetic polymorphisms in *ADH* genes, including *ADH1B*, as instruments for prenatal alcohol exposure, by testing first, whether they predict maternal alcohol intake and patterns of consumption just before and during pregnancy, and second, whether the variants related to alcohol intake are also associated with the likelihood of abstaining from alcohol during pregnancy.

To answer these questions, we analyzed data from mothers of white ethnic origin enrolled in the Avon Longitudinal Study of Parents and Children (ALSPAC).

RESULTS {#s2}
=======

A description of selected participants' characteristics is presented in Table [1](#DDP388TB1){ref-type="table"}. Of the 14 541 pregnant women enrolled in ALSPAC initially, 7410 could be included in the present analysis. Details of exclusions from the study are reported in [Supplementary Material, Fig. S1](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1). Genotype frequencies were similar among those who completed and did not complete the questionnaire (data not shown).

###### 

Selected participants' characteristics

                                                             *N*^a^   Mean (SD) or %
  ---------------------------------------------------------- -------- ----------------
  Age at delivery (years)                                    7410     28 (5)
  BMI before pregnancy (kg/m^2^)                             6594     23.0 (3.9)
  Secondary level education at most (versus higher)          6986     64%
  Manual worker (versus more qualified occupation)^b^        6594     51%
  Smoking pre-pregnancy (yes versus no)                      7344     32%
  Drinking before pregnancy (yes versus no)                  7410     93%
  Drinking in first trimester of pregnancy (yes versus no)   7387     55%
  Binge drinking during pregnancy (yes versus no)^c^         7365     17%

^a^Number with complete data.

^b^On the basis of the highest occupation held either by the woman or her partner (see Materials and Methods for details).

^c^At week 18 of gestation.

Genotype distributions were compatible with no departure from Hardy--Weinberg equilibrium for all SNPs except rs4699714 (*ADH4*) ([Supplementary Material, Table S2](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)). Genotyping success rate was above 93.3% and error rate from duplicates was below 0.25% for all SNPs.

A summary of single-locus association tests between *ADH* genotypes and three dimensions of alcohol drinking before and during pregnancy is presented in Figure [1](#DDP388F1){ref-type="fig"}, where inverse-logged *P*-values are plotted against each SNP\'s chromosomal position. The 'peak' corresponds to a SNP in *ADH1B*, rs1229984, for which there is evidence of association with average alcohol intake before (*P*-value = 0.001) and binge drinking during pregnancy (*P*-value = 9 × 10^−4^) (Fig. [1](#DDP388F1){ref-type="fig"} and Table [2](#DDP388TB2){ref-type="table"}). There is also some evidence of association between rs2866151 (*ADH1A*) and weekly drinking before pregnancy (*P*-value = 0.006) (Fig. [1](#DDP388F1){ref-type="fig"} and Table [2](#DDP388TB2){ref-type="table"}). In general, the associations are stronger when considering drinking before the index pregnancy, and attenuate for drinking during the period following recognition of pregnancy, in particular average weekly drinking in the first trimester (Table [2](#DDP388TB2){ref-type="table"}).

![Association of variation at 10 SNPs in *ADH* and alcohol drinking (additive model). The two horizontal dotted lines refer to a nominal level of statistical significance (*P* = 0.05) and a conservative Bonferroni correction, based on 30 tests---10 SNPs and 3 outcomes (*P* = 0.05/30 = 0.0017).](ddp38801){#DDP388F1}

###### 

Association of variation at 10 SNPs in *ADH* and alcohol drinking (additive model)

  SNP rs-number   Weekly intake before pregnancy   Weekly intake in first trimester   Binge drinking during pregnancy           
  --------------- -------------------------------- ---------------------------------- --------------------------------- ------- -------------------
  rs4699714       1.07 (0.99, 1.15)                0.084                              1.01 (0.91, 1.12)                 0.879   1.07 (0.97, 1.18)
  rs3762894       0.96 (0.88, 1.05)                0.349                              1.04 (0.91, 1.19)                 0.553   1.04 (0.93, 1.17)
  rs4148884       1.00 (0.89, 1.13)                0.947                              0.99 (0.83, 1.18)                 0.935   0.99 (0.85, 1.16)
  rs2866151       1.10 (1.03, 1.17)                0.006                              0.99 (0.90, 1.10)                 0.908   1.01 (0.93, 1.11)
  rs975833        0.97 (0.90, 1.04)                0.394                              1.07 (0.95, 1.20)                 0.254   1.02 (0.92, 1.13)
  rs1229966       0.93 (0.87, 0.99)                0.032                              1.02 (0.92, 1.13)                 0.716   1.04 (0.95, 1.14)
  rs2066701       0.95 (0.88, 1.02)                0.165                              1.01 (0.91, 1.13)                 0.841   1.00 (0.91, 1.10)
  rs4147536       0.93 (0.86, 1.01)                0.073                              0.98 (0.87, 1.10)                 0.708   0.89 (0.80, 1.00)
  rs1229984       0.69 (0.56, 0.86)                0.001                              0.78 (0.53, 1.13)                 0.192   0.55 (0.38, 0.78)
  rs284779        1.03 (0.96, 1.10)                0.398                              1.08 (0.98, 1.20)                 0.105   1.07 (0.98, 1.17)

^a^Odds ratio (OR) of drinking ≥7 units/week versus 1--6 units/week or 1--6 units/week versus \<1 unit/week before pregnancy, from ordinal logistic regression.

^b^Odds ratio of drinking ≥1 units/week versus \<1 unit/week in first trimester of pregnancy, from logistic regression.

^c^Odds ratio of drinking ≥4 units per drinking occasion (binge drinking) around week 18 of gestation, from logistic regression.

In order to account for linkage disequilibrium (LD) in the area (Fig. [2](#DDP388F2){ref-type="fig"}), which could confound association results, Bayesian multilocus models were fitted to these data, separately for the three alcohol measures. Figures in [Supplementary Material, Table S3](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1) represent the probability that a model with one or more SNPs as explanatory variables is selected out of all the possible models in the model space (statistics based on 10 000 iterations with the first 5000 excluded---'burn-in'). Results show a strong effect of rs1229984 on alcohol drinking before pregnancy and binge drinking during pregnancy, independent on the other SNPs in the model. However, for one of the outcomes, drinking in the first trimester of pregnancy, the model with rs1229984 performed worse than the null model (posterior probabilities: 0.08 versus 0.88) ([Supplementary Material, Table S3](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)). The association between rs2866151 and pre-pregnancy drinking disappears when taking into account LD patterns in this multi-locus model. These results are in line with crude associations from classical univariable analyses (Table [2](#DDP388TB2){ref-type="table"}), confirming that the only SNP associated with alcohol use in this study is the established rs1229984, but also that actual weekly intake during the first trimester is the only outcome that does not seem to be associated with genotypes.

![Linkage disequilibrium across the 10 *ADH* SNPs on chromosome 4 calculated as *r*^2^, from Haploview (ALSPAC mothers data).](ddp38802){#DDP388F2}

Additional results for rs1229984 are presented in detail in Table [3](#DDP388TB3){ref-type="table"}. The strong evidence for association between this SNP and average intake before pregnancy but not during pregnancy, and the result showing that it predicts abstention in pregnancy but not before (Table [3](#DDP388TB3){ref-type="table"}), prompted us to investigate whether the variant was associated with the likelihood of drinking cessation in pregnancy. There is strong evidence that women carrying the rare A allele were more likely to quit alcohol during the first trimester of pregnancy \[odds ratio (OR): 1.52; 95% confidence interval (CI): 1.22, 1.91; *P*-value = 0.0004) (Table [4](#DDP388TB4){ref-type="table"}). The evidence remains after adjusting for pre-pregnancy alcohol consumption (*P*-value = 0.004). Weaker evidence is found when looking at the odds of quitting at later stages of gestation, around week 18 and week 32, and these associations seem to be entirely explained by pre-pregnancy intake (Table [4](#DDP388TB4){ref-type="table"}).

###### 

Association between alcohol consumption before and during pregnancy and the rs1229984\*A allele (*ADH1B*) among ALSPAC mothers---dominant effect

  Time period                                          Absolute number   Proportion carrying rare A allele, %   Odds ratio (95% CI)    *P*-value
  ----------------------------------- ---------------- ----------------- -------------------------------------- ---------------------- -----------
  Likelihood of abstaining                                                                                                             
   Before pregnancy                   Yes              498               6.6                                    1.47 (1.01, 2.13)^a^   0.043
  No                                  6607             4.6                                                                             
   First trimester                    Yes              3167              5.8                                    1.55 (1.24, 1.93)^a^   0.0001
  No                                  3923             3.9                                                                             
  Consumption levels among drinkers                                                                                                    
   Before pregnancy                   \<1 drink/week   2713              5.8                                                           
  1--6 drinks/week                    3229             4.1               0.67 (0.54, 0.84)^b^                   0.0005                 
  7+ drinks/week                      836              3.4                                                                             
   First trimester                    \<1 drink/week   2853              4.2                                                           
  1+ drinks/week                      1170             3.3               0.77 (0.53, 1.12)^b^                   0.171                  

^a^Odds ratio of abstaining versus drinking.

^b^Odds ratio of ≥1 units/week versus \<1 unit/week.

###### 

Association between quitting drinking in pregnancy and the rs1229984\*A allele (*ADH1B*) among 6,889 ALSPAC mothers drinking before pregnancy---dominant effect

  Gestational period   No quitted drinking/No still drinking   Model 1^a^          *P*-value   Model 2^b^          *P*-value
  -------------------- --------------------------------------- ------------------- ----------- ------------------- -----------
  First trimester      2680/3911                               1.52 (1.21, 1.91)   0.0004      1.42 (1.12, 1.80)   0.004
  18 weeks             3013/3468                               1.23 (0.98, 1.56)   0.076       1.12 (0.88, 1.43)   0.366
  32 weeks^c^          2614/1441                               1.45 (1.06, 1.98)   0.021       1.28 (0.91, 1.81)   0.155

^a^Model 1 is the unadjusted effect of carrying the allele on the odds of quitting drinking.

^b^Model 2 is the effect of carrying the allele on the odds of quitting drinking, adjusted for the amount of alcohol drunk before pregnancy (\<1 unit/week, 1--6 units/week, ≥7 units/week).

^c^Data only available for 4055 mothers.

The associations between rs1229984 and maternal characteristics known to be generally related to alcohol drinking were analyzed to empirically assess the specificity of the rs1229984-alcohol intake association. For maternal socio-economic status or education, smoking habits, BMI and age at delivery there is no evidence of association; nor is there any association with alcohol drinking behavior of the partner ([Supplementary Material, Table S4](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)). Similarly, since drinking cessation in the first trimester may be due to symptoms of nausea and various food aversions experienced in early pregnancy, we looked at these in association with rs1229984 genotype. There is little evidence of association with nausea or developing aversion to any of the following: coffee, tea, colas or cigarettes ([Supplementary Material, Table S5](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)).

Among women included in the analysis as 'white', 36 reported ethnicity other than white for their mother, father or both. After excluding these in sensitivity analyses, results were largely unchanged (data not shown). Further exclusions based on a set of ancestry-informative genetic markers (*N* = 76 women), or on self-reported Jewish faith (as proxy for Jewish ancestry/ethnicity) (*N* = 4) did not alter the results (not shown---see Materials and Methods for details).

DISCUSSION {#s3}
==========

Summary of results {#s3a}
------------------

We selected 10 candidate polymorphisms in four *ADH* genes and found evidence for a strong inverse association between the A allele of the non-synonymous variant rs1229984 in *ADH1B* and alcohol drinking before pregnancy and binge drinking patterns during pregnancy. Further analyses suggested a role for this variant in predicting drinking cessation particularly in the first trimester. Since the strongest predictor of drinking cessation during pregnancy is alcohol consumption before pregnancy ([@DDP388C34],[@DDP388C35]), we repeated the analyses adjusting for this covariate potentially on the causal pathway, and the evidence remained strong, although there is a small chance that this could still be due to residual confounding, i.e. our inability to capture drinking behaviors with more precision.

This is the first study, to our knowledge, on the role of *ADH* variants on alcohol drinking in women just before and during pregnancy. Strong external pressures exist for pregnant women to modify their behavior and quit alcohol ([@DDP388C30]--[@DDP388C32]). Such pressures might highlight any existing genetic component to drinking behavior, through homogenization of some of the concurrent social determinants of alcohol drinking. However, the extreme-case scenario is that they could result into everybody abstaining from alcohol regardless of their genotype, thus overriding genetic effects. Indeed, we found that carriers of the rs1229984 A allele (*ADH1B*), who before pregnancy were both more likely to abstain and drink less on average, during pregnancy and in particular in the first trimester, were still drinking less, and they were less likely to binge drink and more likely to have stopped drinking altogether. This supports the use of the rs1229984 variant as a candidate instrument for alcohol drinking (versus very little or no drinking) around the time of conception and even more so for binge drinking during pregnancy. This instrument would be highly specific to alcohol behavior, however, the population attributable risk is low given the low prevalence of the variant \[minor allele frequency (MAF) in European origin populations: 2--5% ([@DDP388C23],[@DDP388C24],[@DDP388C36],[@DDP388C37])\].

Strengths and limitations {#s3b}
-------------------------

It is unlikely that genotype data missing for 6000 women would introduce selection bias. Empirical evidence suggests that genotype frequencies are the same for general-population versus selected samples in the UK (the British 1958 birth cohort versus British blood donors from the Wellcome Trust Case--Control Consortium) ([@DDP388C38]), and that genotypes display no more correlation with socioeconomic, lifestyle and physiological phenotypes than expected because of chance ([@DDP388C39]). Moreover, based on our data we found a lack of association of genotypes with socioeconomic and highly socially-patterned factors such as smoking.

We considered the possibility of hidden population substructure explaining the main result for rs1229984. This variant is one of the most ethnically stratified, exhibiting a wide range of MAFs: from 2--5% in Western European populations to 60--70% in North-East Asia ([@DDP388C40]), and alcohol intake is strongly culturally-dependent ([@DDP388C41]). For this reason, we limited the analyses to women of self-reported white ethnicity and conducted sensitivity analyses by further excluding women reporting at least one parent of non-white ethnicity or likely to be 'non-white' based on ancestry-informative markers genotype or self-reported Jewish faith, yet results were unchanged. The lack of genome-wide data on this sample prevented us from running further checks.

Chance is an unlikely explanation of our results. The choice of the candidate variants was informed by a strong biological prior, and for rs1229984, this was in fact an attempt to replicate the association with alcohol intake seen in different contexts. The sample size was large, even by the standards of genetic association studies. The power to detect effect sizes like the ones observed for rs1229984 comparing A allele carriers versus non-carriers was ∼76% for binge drinking during pregnancy and 80% for drinking cessation. Moreover, over-conservative Bonferroni corrections and Bayesian models were used in the first part of the analyses, both accounting for multiple testing. However, the limited phenotypic variation in this sample compared with previous studies ([@DDP388C23],[@DDP388C24]) (approximately 1 versus 3 drinks/week on average for women) could reduce the power to detect associations of alcohol use with other genetic variants with less marked effects.

The usual concern with self-reported alcohol intake is underreporting, both for general population samples ([@DDP388C42]) and pregnant women ([@DDP388C8]). However, underreporting is unlikely to be differential by genotype (under the null hypothesis of no effect on alcohol consumption) and it affects higher intake categories more than moderate and low intake. It is unlikely that under-reporting could explain the observed results, as the heavier drinkers without the A allele could underreport their consumption and declare similar intakes to the A allele carriers, introducing a bias towards the null. Quantity and frequency questions were used to derive pre-pregnancy weekly intake, shown to be generally valid ([@DDP388C43]) and reliable ([@DDP388C44]). Levels of pre-pregnancy drinking reported by ALSPAC participants included in this analysis were considerably lower compared with average alcohol intake of UK women aged 25--34 ([@DDP388C45]), a likely reflection of intentional behavioral change in preparation for the pregnancy. Figures on alcohol consumption during pregnancy were higher than those from surveys from the USA ([@DDP388C46]) and Sweden ([@DDP388C34]) showing that 12 and 30% of women reported consuming alcohol during gestation. Here the figure was 55%, of which only 14% reported drinking more than one drink weekly. Limited data are available on the prevalence of prenatal binge drinking, but a recent French study reported 14% of women consuming five or more drinks on one occasion during pregnancy ([@DDP388C47]), which is similar to our figure of 17% for consuming four or more drinks, whereas a US study found only 2% of pregnant women binge drinking ([@DDP388C46]).

Comparison with published literature {#s3c}
------------------------------------

Rs1229984 is a non-synonymous variant thought to have a functional role. *In vitro* studies predicted up to 40 times higher enzymatic activity comparing carriers versus non-carriers of the A allele ([@DDP388C26]), resulting in faster accumulation of plasma acetaldehyde. This would be aversive, and it is the principle of action of the drug disulfiram, used for treating chronic alcohol dependence (<http://www.bnf.org/bnf/bnf/current/3687.htm>). However, the evidence for *in vivo* effects is limited, possibly because of lack of power arising from a combination of small sample sizes and low prevalence of the variant. A study conducted among 109 Jewish university students in the USA (MAF = 18.5%), reported that carriers of the A allele exhibited higher alcohol elimination rates ([@DDP388C48]). However, this locus contributed little to the total variance explained by genetic variation in the whole *ADH* region in a study of blood and breath ethanol levels among 412 Australian twins ([@DDP388C27]), and similarly a larger and more recent study of *ADH* variation and alcohol metabolism among 812 Australian twins and relatives (MAF = 3.5%) could not find sufficient evidence for an effect of rs1229984 on blood or breath ethanol concentrations ([@DDP388C22]). One study from Japan, where the A allele is extremely prevalent (MAF = 53%), failed to detect an effect on blood levels of acetaldehyde following light drinking (*N* = 68) ([@DDP388C49]), but another reported that extreme levels of drinking in alcoholics (*N* = 80) gave rise to higher blood ethanol and to a lesser extent blood acetaldehyde levels the morning after heavy drinking for carriers of the ancestral G allele (slower metabolizers) ([@DDP388C29]).

The role of rs1229984 on alcohol phenotypes in non-Asian population samples has been studied before, especially in relation to dependence ([@DDP388C23]--[@DDP388C25],[@DDP388C50]--[@DDP388C52]). In addition, a number of studies consistently reported associations between the A allele and reduced alcohol consumption ([@DDP388C23]--[@DDP388C25],[@DDP388C53]--[@DDP388C57]), as well as higher level of response to alcohol ([@DDP388C58]). Most of the samples studied were relatively small (i.e. \<2000) ([@DDP388C25],[@DDP388C53]--[@DDP388C58]). One exception is a study of 9000 Danes presenting evidence of increased alcohol consumption in men not carrying the A allele (OR of heavy drinking for G allele homozygotes versus heterozygotes: 3.1, 95% CI: 1.7, 5.7) ([@DDP388C24]). Another is a recent study from Australia examining 50 *ADH* polymorphisms in association with alcohol intake, confirming rs1229984 as their top hit for most alcohol drinking measures and alcohol-related reactions, with the association between the A allele and reduced overall alcohol consumption approaching 'genome-wide' levels of statistical significance (*P*-value = 8.9 × 10^−8^) ([@DDP388C23]). The above results cannot be directly combined, mainly because of incomplete reporting (*P*-values but no effect estimate) and heterogeneity of populations and alcohol phenotypes presented. However, consistency of the direction of association across all studies as well as *P*-values from the largest studies offer reassurance and strengthen the evidence supporting a role of this SNP in influencing alcohol consumption (sample results from the above cited studies are presented in [Supplementary Material, Table S6](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1) available online).

Our study adds at least two important results to the existing literature: women carrying the rs1229984 A allele are less likely to report episodes of binge drinking during pregnancy and they are more likely to report quitting alcohol during the first trimester. The first finding is in line with previous evidence, and extends this to the extremely sensitive time of pregnancy, when alcohol consumption has several potential adverse effects on the fetus ([@DDP388C10]). The association with drinking cessation is an entirely new result. Whether metabolic changes occurring in pregnancy interact with the effect of the variant, or whether the increased odds of quitting alcohol are due to residual confounding by usual (pre-pregnancy) alcohol intake, we cannot tell.

With the exception of a recent Australian twin study ([@DDP388C23]), no other study has explored the association between alcohol intake and variation across the *ADH* region beyond the classical *ADH1B* and *ADH1C* variants. Most of the evidence relating alcohol behavior to *ADH* variation in non-Asian populations comes from three fine-mapping studies limited to the alcoholism phenotype ([@DDP388C37],[@DDP388C52],[@DDP388C59]), whose results confirmed a role for variation in *ADH1B* ([@DDP388C37],[@DDP388C52],[@DDP388C59]), and suggested one for the *ADH4* gene ([@DDP388C37],[@DDP388C52]), replicating a previous study ([@DDP388C60]). The only data on *ADH4* comparable with this study is an association signal for maximum number of drinks for rs3762894, independent of rs1229984 ([@DDP388C23]). We could not replicate this result when looking at binge drinking during pregnancy, however, a full comparison is hindered because effect estimates are not presented in the Australian publication ([@DDP388C23]).

Variation in *ADH7* has been implicated in the early stages of alcohol metabolism ([@DDP388C22]), however, it is unclear how this affects drinking propensity. A large recent study showed strong evidence of gene \* environment interaction between the non-synonymous SNP rs1573496 and alcohol intake for risk of upper aerodigestive tract cancers ([@DDP388C61]). This SNP has also been shown to be associated with alcohol dependence ([@DDP388C52]) \[not in ([@DDP388C59])\]. A SNP in complete LD with rs1573496 (<http://www.hapmap.org/cgi-perl/gbrowse/hapmap_B35/>) ([@DDP388C62]), rs971074, had also been associated with alcohol dependence ([@DDP388C52]), but other studies failed to confirm the association with either dependence ([@DDP388C23],[@DDP388C37],[@DDP388C59]), or with alcohol use and adverse reactions ([@DDP388C23]). In agreement with these results, the present study does not find evidence of association between *ADH7* variation and alcohol drinking before or during pregnancy.

Few studies have reported on the association between alcohol phenotypes and *ADH1A* polymorphisms, perhaps reflecting the current belief that *ADH1A* enzymes are most active in ethanol metabolism during fetal and early life, gradually losing function in adulthood ([@DDP388C63]). One of the fine-mapping studies on *ADH* variants and alcohol dependence reported signals for three *ADH1A* SNPs ([@DDP388C52]). For two of these SNPs, typed in the present study, we found very modest signals for drinking before pregnancy, in line with published evidence of association between rs3819197 (in strong LD with one of our SNPs) and alcohol consumption ([@DDP388C23]).

Conclusion and implications for future research {#s3d}
-----------------------------------------------

In conclusion, we propose the *ADH1B* variant rs1229984 as a candidate genetic instrument to study the offspring effects of maternal alcohol drinking, in European origin populations. The association of this SNP with alcohol has been established in several adult populations ([@DDP388C23],[@DDP388C24]). Here and for the first time, we present evidence that this effect exists also just before and during pregnancy. However, replication of the present findings in an independent sample is warranted for the ultimate validation of the proposed instrument. A comparable approach to 'instrument identification' has been adopted successfully by Freathy and colleagues, showing that a nicotine receptor gene variant predicts smoking cessation during pregnancy ([@DDP388C64]).

The time around conception and the first trimester are crucially sensitive periods, and the consequences of patterns of drinking that can expose the fetus to high ethanol blood concentrations are of particular concern ([@DDP388C9]). The uncertainty on longer-term effects of *in utero* exposure to ethanol into childhood and even adulthood arises from unreliable reporting of alcohol intake leading to measurement error, as well as residual confounding typical of standard observational studies. For example, it has been suggested that up to 1% of all children could suffer impaired neurodevelopment as a consequence of prenatal alcohol exposure, but solid evidence is lacking ([@DDP388C2]). This highlights the importance of using alternative study designs that control for some or all of these problems, and finally allow interpreting association as causation.

Natural experiments such as studies comparing differentially exposed siblings ([@DDP388C65]) or exposed adoptees with natural offspring have the potential to reduce biases and confounding found in more traditional observational studies, although measurement error remains an issue. Mendelian randomization is one such natural experiment, with the additional advantage of being free from alcohol assessment problems. Causal inference is enhanced by studying genetic markers that are specifically associated with the exposure of interest, but not with other socially-patterned risk factors because genotypes are randomized at conception, and clearly they can be measured objectively ([@DDP388C66]).

In this light, our initial validation of a candidate genetic instrument that predicts lower risk of binge drinking and higher likelihood of giving up alcohol early in gestation, and allows causal inference, takes on a significant public health importance. Implications of the present work are that several phenotypic outcomes could be studied in association with prenatal alcohol exposure, provided maternal *ADH1B* genotype is available. For example, we have estimated through simulations that in an instrumental-variable analysis using rs1229984 as the genetic instrument, approximately 6000 mother--child pairs would be required to find evidence of a causal association between alcohol consumption and a school-based performance score at age 11 (Key Stage 2---<http://en.wikipedia.org/wiki/Key_Stage_2>) at a 5% significance level, assuming a small change of as little as 0.20 standard deviations in the log-transformed outcome comparing A-allele carriers to non-carriers.

These results confirm the existence of a modest genetic contribution to drinking behavior around the time of pregnancy. However, they do not suggest that advice on alcohol drinking during pregnancy should differ according to individual genotype.

MATERIALS AND METHODS {#s4}
=====================

Participants {#s4a}
------------

The ALSPAC is a population-based longitudinal study that recruited 80--90% of pregnant women living in Avon (the English county with Bristol as main urban center) with expected delivery date between April 1991 and December 1992 ([@DDP388C67]). Women of white ethnic origin participating in ALSPAC were eligible for the study reported in this article if they had provided a biological sample for DNA extraction, returned a questionnaire at 18--20 weeks' gestation, and completed the question on pre-pregnancy alcohol consumption. Ethnicity was largely available from self-reported data (*N* = 7359, 90% of those genotyped). For those with missing self-reports but available genotype data (*N* = 601, 7%), white or non-white ethnicity was imputed by regressing the offspring\'s ethnicity as well as genotype of five genetic ancestry-informative markers with established population-specific allelic distributions---rs713598 and rs1726966 in *TAS2R38* ([@DDP388C68]), rs4988235 in *MCM6* ([@DDP388C69]), A44871G in *ASPM* ([@DDP388C70]) and rs930557 in *MCPH1* ([@DDP388C70]).

[Supplementary Material, Fig. S1](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1) available online describes the flow of participants from recruitment into ALSPAC to final inclusion in the current analyses.

Data on alcohol and related phenotypes {#s4b}
--------------------------------------

Mothers completed several questionnaires at enrolment, throughout pregnancy and during their offspring\'s infancy and childhood. In a questionnaire completed at week 18 of gestation, they were asked to recall their alcohol consumption just before the current pregnancy, during the first trimester and in the previous 2 weeks or at the time when they first felt the baby move. Instructions specified that one drink was equivalent to 1 unit (8 g) of alcohol, and one pint of beer to 2 units. Response categories for these questions were: never, \<1 unit/week, ≥1 units/week, 1--2 units/day, 3--9 units/day, ≥10 units/day. After excluding never drinkers, the last three categories were grouped together. Thus three categories were formed to create the variable 'drinking before pregnancy', whereas for 'drinking during first trimester' only two categories were formed (\<1 unit/week and ≥1 units/week), after excluding those who stopped drinking. Around week 32 of gestation, women were asked about their average weekday and weekend alcohol consumption, from which weekly alcohol intake was derived. However, attrition was high (41%) and the format of this variable was different from the other alcohol drinking variables at previous time-points, and therefore it was not used in formal association analyses. Drinking patterns were assessed in a separate question, included in the questionnaires at week 18 of gestation, which asked about the number of days in the previous 4 weeks that the mother had consumed at least 4 units of alcohol \[defined as 'binge drinking' occasions for the purpose of this study ([@DDP388C71])\]\]. Response categories were 0, 1--2, 3--4, 5--10 or ≥10 days. For the analyses, consuming at least 4 units of alcohol on one or more days around week 18 was considered 'binge drinking during pregnancy'. Drinking cessation at various time-points was defined as non-drinking at those time-points, for women who were drinking before the index pregnancy.

Maternal age at delivery was derived from date of birth, collected at enrollment. Maternal and socio-demographic variables obtained during pregnancy were categorized for analysis: family social class (based on the highest occupation among the woman and her partner and dichotomized into manual versus otherwise, using the 1991 British Office of Population and Census Statistics classification); highest level of maternal education (secondary level academic qualification---'O' level---or higher versus lower); smoking before the current pregnancy (yes versus no); heavy smoking before the current pregnancy (≥15 cigarettes/day versus fewer); overweight before the current pregnancy \[body mass index (BMI) ≥25 versus less\]. Questions on nausea and recent changes in consumption of coffee, tea, cola, alcohol and cigarettes were included in the questionnaire completed in the first trimester of gestation. On the basis of questionnaires completed by partners themselves, data were derived on partner\'s alcoholism (ever suffered from alcoholism versus never) and alcohol drinking habits (≥1 units/day versus less, before the pregnancy).

Further details are included in the study protocol ([@DDP388C67]) or can be found on the ALSPAC website (<http://www.alspac.bris.ac.uk>). Ethical approval was obtained from the ALSPAC Law and Ethics Committee (IRB 00003312) and the Local Research Ethics Committee.

Genotyping {#s4c}
----------

Ten SNPs were selected based on published evidence of functionality (i.e. rs1229984 in *ADH1B*) or association with alcohol-related phenotypes, and typed as part of an investigation of the role of maternal drinking on childhood growth and development in ALSPAC. Efforts were made to choose a set of independent common polymorphisms (MAF ≥ 0.05 for all except rs1229984). Coverage of *ADH1A* in particular (3 SNPs), whose related enzymes are most active during fetal and early life ([@DDP388C63]), reflects the scope of the study for which the genotyping was done. The prior for inclusion in the study for each SNP was not assessed through a formal meta-analysis of published associations, which was impossible because of the limited evidence presented. Rather, we looked for consistency of association across the different studies that reported results for a particular SNP, as well as evidence of functionality. We acknowledge that this strategy has the shortcoming of not being fully replicable.

DNA was extracted from peripheral blood taken during pregnancy as described previously ([@DDP388C72]). SNPs were genotyped by KBioscience (<http://www.kbioscience.co.uk>) using the KASPar chemistry, a competitive allele-specific PCR system using FRET quencher cassette oligos (<http://www.kbioscience.co.uk/genotyping/genotyping-chemistry.htm>). Blind duplicates, plate-identifying repeat samples and Hardy--Weinberg equilibrium tests were used as quality control checks.

Statistical analyses {#s4d}
--------------------

Analyses were restricted to women of white ethnic origin. Associations between the SNPs and alcohol intake variables were tested in univariable models assuming additive effects of rare alleles. For SNPs with MAF \< 0.05, rare homozygotes and heterozygotes were analyzed together and a dominant effect was assumed. Logistic regression was used for binary outcomes and ordinal logistic regression for ordered categorical variables (e.g. average weekly drinking before pregnancy---\<1 unit/week, 1--6 units/week, ≥7 units/week).

Despite our efforts to select variants that are as independent of each other as possible, not all of the pair-wise correlations would be null. This means that signals from the crude analysis could have been confounded by some other SNPs because of LD, which is high in the *ADH* region. In order to identify independent genetic effects, Bayesian models were fitted to the data for each of the three alcohol phenotypes. These models account for LD patterns in the data and also for multiple testing. SNPs are kept in the model based on their probability of explaining variation in the outcome in relation to the performance of all the other SNPs, which can enter the model individually or in combination ([@DDP388C73]). The variable selection follows a reversible-jump algorithm based on a binomial prior distribution, with parameter for the number of trials being the total number of predictors included in the model, and the parameter for probability of 'success' equal to 0.5 ([@DDP388C73]). This ensures all possible models are equally likely a priori. Ten thousand iterations were completed, with the first 5000 specified as burn-in.

Top hits identified in the first phase of analyses were regressed against the likelihood of drinking cessation at different time-points during pregnancy, in crude analyses as well as adjusting for pre-pregnancy alcohol consumption levels (likely on the causal pathway).

To empirically assess the specificity of the *ADH1B* variant-alcohol intake associations, the OR of selected participant\'s and partner\'s characteristics were derived comparing carriers of the rs1229984 A allele versus non-carriers, and those drinking \<1 unit/week before pregnancy versus those drinking ≥1 units/week ([Supplementary Material, Table S4](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)). Similarly, since abstaining in the first trimester could be explained by symptoms of nausea and food aversions, we looked at these in association with rs1229984 ([Supplementary Material, Table S5](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)).

Since rs1229984 shows extreme stratification in different populations worldwide ([@DDP388C40]), and alcohol drinking follows cultural patterns ([@DDP388C41]), there is a possibility of residual confounding by population substructure, even if the sample analyzed only included women reporting white/European ethnicity. To assess this, we conducted sensitivity analyses by further excluding women following two more conservative definitions of 'white ethnicity': one based on the woman\'s reported parental ethnicity, and her own; another based on a set of ancestry-informative genetic markers. Finally, we repeated the analyses after excluding all women reporting to be of Jewish religious faith, as a proxy for Jewish ancestry/ethnicity. This was done since the prevalence of the A allele is much higher in populations from West Asia including Jews from a variety of regions ([@DDP388C74]), who might also drink less than other individuals of European ancestry that would equally describe themselves as 'white'.

Statistical analyses were performed in Stata 10 and WinBugs ([@DDP388C75]). Pair-wise LD across the 10 SNPs (as *r*^2^) was computed using Haploview ([@DDP388C76]).

SUPPLEMENTARY MATERIAL {#s5}
======================

[Supplementary Material is available at *HMG* online.](http://hmg.oxfordjournals.org/cgi/content/full/ddp388/DC1)
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